ALEXZA PHARMACEUTICALS INC's ticker is ALXA and the CUSIP is 015384209. A total of 40 filers reported holding ALEXZA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.04 and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $24,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LANSDOWNE PARTNERS AUSTRIA GMBH | 1,212,555 | $5,262,000 | 100.00% |
| HOWARD HUGHES MEDICAL INSTITUTE | 98,914 | $429,000 | 0.14% |
| Rotella Capital Management, Inc. | 10,000 | $43,000 | 0.14% |
| BBT Capital Management, LLC | 132,533 | $575,000 | 0.03% |
| Jefferies Group LLC | 477,500 | $2,072,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 246,473 | $1,070,000 | 0.02% |
| LANSDOWNE PARTNERS LIMITED PARTNERSHIP | 307,500 | $1,335,000 | 0.02% |
| FEDERATED HERMES, INC. | 674,300 | $2,926,000 | 0.01% |
| KNIGHT CAPITAL GROUP LLC | 61,466 | $265,000 | 0.01% |
| CREDIT SUISSE AG/ | 654,292 | $2,839,000 | 0.00% |